April 15 (Reuters) – Kimberly-Clark on Wednesday said its chief financial officer, Nelson Urdaneta, will become the finance chief of the combined company it will create after completing its $40-billion acquisition of Tylenol-maker Kenvue. The deal, announced in November, is expected to close in the second half of 2026, pending regulatory approvals. * The new […]
Health
Kimberly-Clark retains Urdaneta as CFO of combined company after $40-billion Kenvue deal
Audio By Carbonatix
April 15 (Reuters) – Kimberly-Clark on Wednesday said its chief financial officer, Nelson Urdaneta, will become the finance chief of the combined company it will create after completing its $40-billion acquisition of Tylenol-maker Kenvue.
The deal, announced in November, is expected to close in the second half of 2026, pending regulatory approvals.
* The new entity will operate with four business segments:North America, Asia Pacific Focus Markets, Europe-MiddleEast-Africa (EMEA), and Enterprise Markets, each led by regionalpresidents. * Russ Torres will serve as group president and chiefoperating officer, while other senior roles include chief growthofficer, chief R&D officer and chief supply chain officer. * Kimberly-Clark said more than 30 teams working on theintegration have identified opportunities to grow the businessand reduce costs. * The acquisition of the former Johnson & Johnson unit,Kimberly-Clark’s largest-ever deal, is set to create a globalhealth and wellness giant with annual sales of roughly $32billion, expanding the company’s reach in consumer health andpersonal care. * Upon closing, Kimberly-Clark’s CEO, Mike Hsu, is set totake over as the top boss and chairman of the combined company,it had said at the time of the deal.
(Reporting by Savyata Mishra in Bengaluru; Editing by Sahal Muhammed)